Characterization of an NBS1 C-terminal peptide that can inhibit ataxia telangiectasia mutated (ATM)-mediated DNA damage responses and enhance radiosensitivity.

Source:http://linkedlifedata.com/resource/pubmed/id/17507690

Download in:

View as

General Info

PMID
17507690